Abstract
Some PCTs acquire the Spearhead designation despite having only a small geographic overlap with a Spearhead LA, and this may give an unduly favourable image of health inequalities. Where only a small proportion of the resident population of a PCT lies within the LA from which it derives Spearhead status, the rest of the PCT population may be comparatively affluent. This could lead to overestimation of survival in Spearhead PCTs compared with that in truly deprived groups. Any observed deficit in survival between Spearhead and non-Spearhead PCTs could thus be an underestimation of the 'real' survival deficit.
Inequalities in cancer survival are well documented in England. Cancer patients resident in Spearhead PCTs have significantly lower survival than in all other PCTs (Ellis et al. 2009 ), although studies using small-area measures of deprivation have identified more substantial survival gradients between deprived and affluent populations (Coleman et al., 2004; Rachet et al., 2008) .
We have therefore compared differences in cancer survival between populations in Spearhead and other LAs and the corresponding differences between populations resident in Spearhead and other PCTs. These comparisons will provide insight into the impact of different geographical boundaries on cancer survival indicators.
Methods
Cancer incidence data were provided by the National Cancer Registry at the Office for National Statistics. Analyses included all adults (aged 15-99) resident in England who were diagnosed during 2000-2004 (before the introduction of the Spearhead group) with one of ten common cancers (bladder, breast, cervix, colon, lung, oesophagus, ovary, prostate, rectum, stomach) as a first, primary, malignant neoplasm, and who were followed up until 31 December 2005 (see Rachet et al. 2008 for details of exclusion criteria).
Five-year age-standardised relative survival for each cancer was estimated separately for patients resident in Spearhead and all other LAs, and Spearhead and all other PCTs. Relative survival is the ratio of the observed (crude) survival of the cancer patients and the survival that would have been expected if those patients had experienced only the same age and sex-specific mortality rates (background mortality) as the general population from which they are drawn (Estève et al., 1990; Ederer et al., 1961; Cutler and Ederer, 1958) . Life tables containing all-cause mortality rates by single year of age, sex, Government Office Region (GOR) and deprivation category were used to represent background mortality. A maximum likelihood approach of calculating crude and relative survival from individual tumour records was applied (Estève et al., 1990) , using an algorithm developed for previous analyses (Coleman et al., 1999) . Survival was lower in the Spearhead areas (whether defined by PCT or LA) than in the rest of England for most of the 16 cancer-sex combinations examined. The exceptions were cancers of the stomach (men), ovary, and prostate, where survival was higher in the Spearhead areas than the rest of England, although these differences were not statistically significant (Table 1) . These survival estimates are not age-standardised due to small numbers of cases in some age strata Five-year survival was lower in Spearhead LAs than Spearhead PCTs for 11 of the 16 cancer-sex combinations examined, although absolute differences were minimal (-0.1% to -0.7%). As a consequence, the difference in survival between the Spearhead areas and the rest of England (the survival gap) was slightly wider when the definition was based on LAs rather than PCTs (Figure 1 ). Somewhat larger differences are seen for cancers of the bladder (men) and colon (both sexes), where the survival gap differs by -0.8 per cent and -0.6 per cent, respectively, between Spearhead LAs and Spearhead PCTs. Conversely, for six other cancer-sex combinations, the survival gap was slightly wider when analyses are performed using Spearhead PCTs. Even the largest differences between PCT-based and LA-based comparisons for cancer of the bladder (0.8 per cent) in women and for prostate cancer (0.4 per cent) are still small.
Discussion
These results show that for most common cancers, the deficit in five-year survival between Spearhead LAs and the rest of England is indeed slightly wider than between Spearhead PCTs and the rest of England. Health policies designed to reduce inequalities, based as they are on Spearhead PCTs, will thus be slightly easier to achieve than if they had been based on Spearhead Local Authorities, at least for cancer survival. However, the differences between using Spearhead LAs or Spearhead PCTs to estimate the survival gap are small.
We had assumed that the designation of Spearhead PCTs would result in an underestimation of the survival deficit between deprived and affluent populations, presenting an unduly favourable image of the gap in cancer survival at baseline. Whilst slight differences were found between using Spearhead LAs and Spearhead PCTs in the estimation of cancer survival, the results were neither consistent enough, nor large enough, to support this concern.
These analyses do show that survival is consistently lower for patients resident in Spearhead areas than in the rest of England for the majority of cancers, regardless of the geographic unit used, although previous analyses suggest that the gap in survival was narrowing even before the introduction of the Spearhead Group in 2004 (Ellis et al., 2009 ).
Conclusion
The gap in five-year survival between Spearhead LAs and the rest of England is slightly wider than between Spearhead PCTs and the rest of England. Differences are small however, and we conclude that Spearhead PCTs are an acceptable geographic unit for monitoring inequalities in cancer survival.
However, in July 2010 the Government White Paper 'Equity and excellence: liberating the NHS' proposed the abolition of Primary Care Trusts, replacing them with new local GP consortiums (Department of Health, 2010) . The impact of this restructuring on the Spearhead Group is as yet unknown. Given the small differences in cancer survival estimated using PCTs and LAs reported here, Spearhead LAs would appear to be a suitable alternative geographic unit.
